Cargando…
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
The purpose of this study was to identify risk factors in patients with surgically treated node-positive IB1-IIB cervical cancer and to establish a risk model for disease-free survival (DFS) and overall survival (OS). A total of 170 patients who underwent radical hysterectomy and bilateral pelvic ly...
Autores principales: | Chen, Zhilan, Huang, Kecheng, Lu, Zhiyong, Deng, Song, Xiong, Jiaqiang, Huang, Jia, Li, Xiong, Tang, Fangxu, Wang, Zhihao, Sun, Haiying, Wang, Lin, Zhou, Shasha, Wang, Xiaoli, Jia, Yao, Hu, Ting, Gui, Juan, Wan, Dongyi, Ma, Ding, Li, Shuang, Wang, Shixuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892859/ https://www.ncbi.nlm.nih.gov/pubmed/27313462 http://dx.doi.org/10.2147/OTT.S94151 |
Ejemplares similares
-
Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery
por: Sun, Haiying, et al.
Publicado: (2018) -
Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016) -
Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016) -
Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014) -
The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study
por: Li, Xiong, et al.
Publicado: (2015)